Literature DB >> 22986088

Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer.

Milan S Geybels1, Bas A J Verhage, Frederik J van Schooten, Piet A van den Brandt.   

Abstract

PURPOSE: Oxidative stress is possibly related to prostate carcinogenesis. We constructed a dietary antioxidant score, which is a measure of combined antioxidant exposures, and an oxidative balance score (OBS), which is a measure of combined antioxidant and pro-oxidant exposures. We hypothesized that both scores are inversely associated with the risk of prostate cancer (PCa).
METHODS: We conducted a case-cohort study among 58,279 men in the Netherlands Cohort Study. Cohort members completed a baseline questionnaire. From 1986 to 2003, 3451 patients with PCa were identified including 1196 advanced cancers (stage III/IV). The antioxidant score and the OBS were created by summing quartile and category scores of individual score constituents, which had an equal weight. Pro-oxidants were scored in the opposite way to antioxidants.
RESULTS: Both the antioxidant score and OBS were not associated with risk of overall PCa or PCa subgroups on the basis of disease stage. Most score constituents were not associated with the risk of PCa. Total catechin intake was associated with a decreased risk of stage IV PCa (greatest vs. lowest quartile: hazard ratio, 0.76; 95% confidence interval, 0.59-0.98).
CONCLUSIONS: The antioxidant score and OBS were not associated with risk of overall and advanced-stage PCa.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986088     DOI: 10.1016/j.annepidem.2012.07.010

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  8 in total

1.  Oxidative balance score as predictor of all-cause, cancer, and noncancer mortality in a biracial US cohort.

Authors:  So Yeon Kong; Michael Goodman; Suzanne Judd; Roberd M Bostick; W Dana Flanders; William McClellan
Journal:  Ann Epidemiol       Date:  2015-01-16       Impact factor: 3.797

2.  Total antioxidant intake in relation to prostate cancer incidence in the Health Professionals Follow-Up Study.

Authors:  Kjell M Russnes; Kathryn M Wilson; Mara M Epstein; Julie L Kasperzyk; Meir J Stampfer; Stacey A Kenfield; Sigbjørn Smeland; Rune Blomhoff; Edward L Giovannucci; Walter C Willett; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2013-11-11       Impact factor: 7.396

Review 3.  A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.

Authors:  Farhad Islami; Daniel M Moreira; Paolo Boffetta; Stephen J Freedland
Journal:  Eur Urol       Date:  2014-09-18       Impact factor: 20.096

4.  Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study.

Authors:  Kjell M Russnes; Elisabeth Möller; Kathryn M Wilson; Monica Carlsen; Rune Blomhoff; Sigbjørn Smeland; Hans-Olov Adami; Henrik Grönberg; Lorelei A Mucci; Katarina Bälter
Journal:  BMC Cancer       Date:  2016-07-11       Impact factor: 4.430

Review 5.  Index-Based Dietary Patterns and the Risk of Prostate Cancer.

Authors:  Ji Hyun Kim; Jeongseon Kim
Journal:  Clin Nutr Res       Date:  2017-09-27

Review 6.  Iron Metabolism in Prostate Cancer; From Basic Science to New Therapeutic Strategies.

Authors:  Driton Vela
Journal:  Front Oncol       Date:  2018-11-27       Impact factor: 6.244

7.  Association of Oxidative Balance Score with the Metabolic Syndrome in a Sample of Iranian Adults.

Authors:  Zahra Noruzi; Ahmad Jayedi; Mena Farazi; Elaheh Asgari; Fatemeh Dehghani Firouzabadi; Zahra Akbarzadeh; Kurosh Djafarian; Sakineh Shab-Bidar
Journal:  Oxid Med Cell Longev       Date:  2021-05-26       Impact factor: 6.543

Review 8.  Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans.

Authors:  Martha A Sánchez-Rodríguez; Víctor Manuel Mendoza-Núñez
Journal:  Oxid Med Cell Longev       Date:  2019-11-25       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.